.jpg)
In the field of deep learning applied to medical imaging, the quality of training data labels is a critical factor that determines model performance. Recent research has shown that up to 10% of manually labeled images may contain errors, introducing noise and degrading the generalization ability of computer-aided diagnosis systems. Faced with this challenge, there is a need to develop automatic mechanisms to identify and correct these incorrect labels without relying exclusively on intensive human review.
A promising approach is based on analyzing loss function sequences across multiple training epochs in deep classification networks. The underlying idea is that mislabeled samples tend to exhibit atypical loss patterns, such as persistently high values or erratic fluctuations, compared to correctly labeled samples. By monitoring these curves, it is possible to efficiently filter suspicious images and subject them to expert review. This method has been experimentally validated on retinography datasets for diabetic retinopathy detection, successfully recovering over 75% of incorrect labels with a false positive rate below 5%. After correction, the retrained model achieved accuracy close to that obtained with completely clean data, confirming the practical value of this technique.
Implementing such solutions requires deep knowledge of neural network architectures, time series analysis techniques, and integration workflows with clinical systems. At Q2BSTUDIO, as a company specialized in software development and technology, we offer artificial intelligence services for businesses that range from automated error detection in data to deploying robust models in production. Our team combines expertise in AI for businesses with capabilities in custom applications and custom software, allowing us to adapt these algorithms to specific domains such as radiology, digital pathology, or ophthalmology.
Furthermore, efficient management of these processes requires scalable infrastructures. Therefore, we integrate AWS and Azure cloud services to orchestrate distributed training, storage of large volumes of images, and automation of data pipelines. We also incorporate business intelligence services and Power BI to visualize labeling quality metrics and model performance, facilitating decision-making by clinical teams. Cybersecurity is equally relevant: protecting patient privacy and data integrity is a priority, so we include cybersecurity and pentesting services in our implementations.
Looking to the future, the combination of error detection methods with autonomous AI agents will not only identify incorrect labels but also suggest corrections or even relabel images semi-automatically, reducing the workload for specialists. At Q2BSTUDIO, we are committed to responsible innovation, developing custom applications that improve data quality and, ultimately, the accuracy of diagnoses assisted by artificial intelligence.
